Pre-op Avatrombopag Curbs Platelet Need in Patients With Liver Disease Pre-op Avatrombopag Curbs Platelet Need in Patients With Liver Disease
Pre-procedural avatrombopag (Doptelet, Dova) may reduce the need for platelet transfusions or rescue procedures for bleeding in patients with chronic liver disease (CLD) and thrombocytopenia, according to findings from two phase 3 trials.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 5, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

FDA Approves Doptelet (avatrombopag) for Thrombocytopenia Patients with Chronic Liver Disease who are Undergoing a Medical Procedure
May 21, 2018 -- The U.S. Food and Drug Administration today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who are scheduled to undergo a medical or dental... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 21, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Doptelet (avatrombopag) for Chronic Liver Disease Patients with Thrombocytopenia who are Undergoing a Medical Procedure
May 21, 2018 -- The U.S. Food and Drug Administration today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who are scheduled to undergo a medical or dental... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 21, 2018 Category: Drugs & Pharmacology Source Type: news

FDA OKs Platelet Booster for Liver Disease Patients FDA OKs Platelet Booster for Liver Disease Patients
Avatrombopag increases platelet counts and may decrease or eliminate the need for transfusions in patients with liver disease and thrombocytopenia who are to undergo a planned medical or dental procedure.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 21, 2018 Category: Consumer Health News Tags: Gastroenterology News Alert Source Type: news

Toxic thrombocytopenia during Nerium oleander poisoning - Bataille C, Capaldo L, Courtois A, Seguy B, Lotiron C, Labadie M.
[Abstract unavailable] Language: en... (Source: SafetyLit)
Source: SafetyLit - May 21, 2018 Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news

FDA approves new drug for patients with chronic liver disease who have low blood platelets and are undergoing a medical procedure
FDA approves Doptelet (avatrombopag) to treat thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a medical procedure. (Source: Food and Drug Administration)
Source: Food and Drug Administration - May 21, 2018 Category: American Health Source Type: news

FDA Approves Tavalisse (fostamatinib disodium hexahydrate) for Chronic Immune Thrombocytopenia
SOUTH SAN FRANCISCO, Calif., April 17, 2018 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that the U.S. Food and Drug Administration (FDA) approved Tavalisse (fostamatinib disodium hexahydrate) for the treatment of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 17, 2018 Category: Drugs & Pharmacology Source Type: news

Severe fever with thrombocytopenia syndrome complicated by invasive aspergillosis
Tue, 03/27/2018 - 14:06News blog (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - March 27, 2018 Category: Respiratory Medicine Authors: ROrritt Source Type: news

Akers Bio signs 3-year distribution deal with Diagnostica Stago
Akers Biosciences Inc. has entered into a three-year national distribution agreement for its flagship product with Diagnostica Stago Inc. Under the three-year deal, Stago will distribute South Jersey-based Akers PIFA PLUSS PF4 Rapid Assay, a single-use test for Heparin-induced thrombocytopenia to its customer base of hospital laboratories across the United States. Heparin-induced thrombocytopenia (HIT) is a clinical syndrome that r everses heparin's intended blood-thinning therapeutic effect and… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - March 26, 2018 Category: Health Management Authors: John George Source Type: news

Akers Bio signs 3-year distribution deal with Diagnostica Stago
Akers Biosciences Inc. has entered into a three-year national distribution agreement for its flagship product with Diagnostica Stago Inc. Under the three-year deal, Stago will distribute South Jersey-based Akers PIFA PLUSS PF4 Rapid Assay, a single-use test for Heparin-induced thrombocytopenia to its customer base of hospital laboratories across the United States. Heparin-induced thrombocytopenia (HIT) is a clinical syndrome that r everses heparin's intended blood-thinning therapeutic effect and… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 26, 2018 Category: Biotechnology Authors: John George Source Type: news

Pacritinib May Benefit Patients with Myelofibrosis and Thrombocytopenia
A recent phase III study revealed a benefit with pacritinib for patients with myelofibrosis and thrombocytopenia who have experienced treatment failure with previous therapies. (Source: CancerNetwork)
Source: CancerNetwork - March 21, 2018 Category: Cancer & Oncology Authors: John Schieszer Tags: Hematologic Malignancies Myeloproliferative Neoplasms News Source Type: news

Pacritinib Can Fill Unmet Need in Myelofibrosis Pacritinib Can Fill Unmet Need in Myelofibrosis
Investigational agent pacritinib holds promise as a treatment option for patients with myelofibrosis and baseline thrombocytopenia.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 13, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Antiplatelet Therapy in ACS Patients With Thrombocytopenia Antiplatelet Therapy in ACS Patients With Thrombocytopenia
ACS patients with thrombocytopenia are at higher risk of both bleeding and ischemic events, making treatment particularly challenging. How should management be approached?European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 6, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Romiplostim Not Tied to Leukemic Progression in Myelodysplastic Syndromes Romiplostim Not Tied to Leukemic Progression in Myelodysplastic Syndromes
Contrary to initial reports, romiplostim treatment of thrombocytopenia does not appear to increase the risk of progression from myelodysplastic syndrome (MDS) to acute myeloid leukemia (AML).Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 2, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Your NEJM Group Today: Headache, Anemia, and Thrombocytopenia / Top Gastroenterology Stories / California Faculty Positions
Here's what we've chosen for you today from NEJM Group: NEJM Clinical Practice Center: Case Record: A 32-year-old woman was admitted to the... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 4, 2018 Category: Primary Care Source Type: news

Rigel Announces Departure of Chief Financial Officer
Launches Search for Chief Financial Officer with Commercial-Stage Expertise SOUTH SAN FRANCISCO, Calif., Dec. 15, 2017 -- (Healthcare Sales & Marketing Network) -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the resignation of Ryan Mayna... Biopharmaceuticals, Personnel Rigel Pharmaceuticals, fostamatinib, tyrosine kinase, thrombocytopenia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 15, 2017 Category: Pharmaceuticals Source Type: news

Novartis says ‍revolade shows long-term disease control for chronic/persistent immune thrombocytopenia​
ZURICH (Reuters) - Novartis said on Wednesday a long term study of ‍its Revolade drug showed good results in treating chronic and persistent immune thrombocytopenia (ITP) - a condition where patients' blood does not clot normally. (Source: Reuters: Health)
Source: Reuters: Health - October 18, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Rigel Welcomes Brian Kotzin, M.D. to Board of Directors
SOUTH SAN FRANCISCO, Calif., Aug. 25, 2017 -- (Healthcare Sales & Marketing Network) -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Brian L. Kotzin, M.D. has been appointed to Rigel's board of directors. A well-respected former profess... Biopharmaceuticals, Personnel Rigel Pharmaceuticals, Tavalisse, fostamatinib, immune thrombocytopenia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 25, 2017 Category: Pharmaceuticals Source Type: news

FDA Accepts Rigel's New Drug Application for TAVALISSE(TM) (fostamatinib disodium) for the Treatment of Chronic ITP
SOUTH SAN FRANCISCO, Calif., June 19, 2017 -- (Healthcare Sales & Marketing Network) -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the U.S. Food and Drug Administration (FDA) has filed its New Drug Application (NDA) for the use of TAVALISS... Biopharmaceuticals, FDA Rigel Pharmaceuticals, TAVALISSE, fostamatinib, thrombocytopenia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2017 Category: Pharmaceuticals Source Type: news

A Newborn With Cutaneous Lesions and Hematochezia A Newborn With Cutaneous Lesions and Hematochezia
Can you identify the underlying cause of this newborn's dermal lesion, thrombocytopenia, and rectal bleeding?Medscape Pediatrics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 12, 2017 Category: Consumer Health News Tags: Pediatrics Clinical Case Source Type: news

What Causes Anemia?
Discussion One of the most common problems in pediatrics is anemia. It is defined as “a lower than normal value for the related measurements of hemoglobin, hematocrit, and number of red blood cells”, usually 2 standard deviations below the normal for age. Normal hematological values change with age. For a discussion of which values are used click here. The most common type of anemia in childhood is iron deficiency which is commonly caused by inadequate stores (e.g. premature infant), inadequate intake (e.g. poor nutrition) or blood loss (e.g. menses). Anemia screening is recommended at age 9-12 months, and for...
Source: PediatricEducation.org - May 15, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Rigel Announces Tavalisse(TM) as Proprietary Name for Fostamatinib in the United States
SOUTH SAN FRANCISCO, Calif., April 27, 2017 -- (Healthcare Sales & Marketing Network) -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that the U.S. Food and Drug Administration (FDA) has conditionally accepted the proprietary name Tavalisse™... Biopharmaceuticals, Oncology Rigel Pharmaceuticals, Tavalisse, fostamatinib, immune thrombocytopenia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 27, 2017 Category: Pharmaceuticals Source Type: news

Rigel Pharmaceuticals submits NDA to FDA for Fostamatinib to treat chronic ITP
Rigel Pharmaceuticals has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for an oral investigational drug candidate, Fostamatinib, for the treatment of chronic and persistent immune thrombocytopenia (ITP). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - April 18, 2017 Category: Pharmaceuticals Source Type: news

Rigel Submits New Drug Application to FDA for Fostamatinib in Chronic ITP
SOUTH SAN FRANCISCO, Calif., April 17, 2017 -- (Healthcare Sales & Marketing Network) -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for fosta... Biopharmaceuticals Rigel Pharmaceuticals, fostamatinib, immune thrombocytopenia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 17, 2017 Category: Pharmaceuticals Source Type: news

Presentation of Severe Fever With Thrombocytopenia Syndrome Presentation of Severe Fever With Thrombocytopenia Syndrome
This case details an unusual presentation of encephalopathy in a patient with severe fever with thrombocytopenia syndrome, an emerging infectious disease that has recently been identified in Asia.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 14, 2017 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Eltrombopag Improved Platelet Counts in Thrombocytopenic MDS Patients
The use of the thrombopoietin receptor agonist eltrombopag was clinically effective at raising platelet counts in patients with lower-risk myelodysplastic syndromes with severe thrombocytopenia. (Source: CancerNetwork)
Source: CancerNetwork - February 10, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Hematologic Malignancies Myelodysplastic Syndromes News Source Type: news

Ocular Complications of Congenital Infections
This article summarizes the ocular complications of the 5 infections typically represented by the acronym TORCHES (toxoplasmosis, rubella, cytomegalovirus, herpes simplex, and syphilis), as well as others, including newer pathogens such as the human immunodeficiency, West Nile, and Zika viruses. (Source: NeoReviews recent issues)
Source: NeoReviews recent issues - January 31, 2017 Category: Pediatrics Authors: Khazaeni, L. M. Tags: Pediatric Drug Labeling Update Articles Source Type: news

[Report] IgG antibodies to dengue enhanced for Fc γRIIIA binding determine disease severity
Dengue virus (DENV) infection in the presence of reactive, non-neutralizing immunoglobulin G (IgG) (RNNIg) is the greatest risk factor for dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS). Progression to DHF/DSS is attributed to antibody-dependent enhancement (ADE); however, because only a fraction of infections occurring in the presence of RNNIg advance to DHF/DSS, the presence of RNNIg alone cannot account for disease severity. We discovered that DHF/DSS patients respond to infection by producing IgGs with enhanced affinity for the activating Fc receptor FcγRIIIA due to afucosylated Fc glycans and IgG1...
Source: ScienceNOW - January 26, 2017 Category: Science Authors: Taia T. Wang Source Type: news

Severe Thrombocytopenia in a Child With Typhoid Fever Severe Thrombocytopenia in a Child With Typhoid Fever
How should thrombocytopenia in typhoid fever be managed? The successful outcome of this occurrence in a young traveler provides some guidance.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 6, 2017 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news

Amgen Announces Presentation Of New Data In Acute Lymphoblastic Leukemia, Multiple Myeloma And Immune Thrombocytopenia At ASH 2016
Sub-Analysis From Phase 3 TOWER Study Compares Health-Related Quality of Life of BLINCYTO® (Blinatumomab) to Standard of Care Chemotherapy Analysis of Phase 3 Data Evaluates Cost-Effectiveness of KYPROLIS® (Carfilzomib) in Combination With Dexamethasone for Relapsed Multiple Myeloma Patients Long-Term Data Provide Insights on Safety and Efficacy of Nplate® (Romiplostim) in Children With Immune Thrombocytopenia THOUSAND OAKS, Calif., Nov. 30, 2016 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new data will be presented at the 58th Annual Meeting and Exposition of the American Society of Hemat...
Source: Amgen News Release - November 30, 2016 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Assessing Fever in Returning Travelers: Part II
  Zika continues to be the virus of the day for returning travelers, but there are several other diseases that we need to consider in these patients when they present to us in the emergency department. Chikungunya is epidemic in many of the same countries as Zika and can be even more devastating. And Avian and MERS-CoV is still present in many countries. Unlike patients infected with Zika virus, these patients do require isolation to protect our health care staff from infection. Chikungunya Chikungunya, which means “to walk bent over,” was likely endemic but unrecognized in the United States before the mos...
Source: EPMonthly.com - November 25, 2016 Category: Emergency Medicine Authors: Matt McGahen Tags: Uncategorized Source Type: news

Middle-Aged Man With Acute Thrombocytopenia Subsequent to Fluorouracil and Oxaliplatin Chemotherapy for Colorectal Cancer
A 44-year-old patient with a history of stage IIB colorectal cancer at the hepatic flexure, invading the duodenum and pancreas, was initially diagnosed in September 2005 and received modified Whipple surgery and 8 cycles of adjuvant chemotherapy with capecitabine and oxaliplatin every 3 weeks. (Source: CancerNetwork)
Source: CancerNetwork - November 15, 2016 Category: Cancer & Oncology Authors: Henning Schade, MD Lindsey Davis, MD Peter Kabos, MD Tags: Case Studies Colorectal Cancer Oncology Journal Source Type: news

Mayo Clinic PathWays: What's the diagnosis?
This week's case involves?review of a peripheral smear from a 42-year-old man with lifelong mild thrombocytopenia. View the case and make your diagnosis. Learn more about Mayo Clinic PathWays. (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 19, 2016 Category: Databases & Libraries Source Type: news

Preterm Thrombocytopenia Tied to Delayed Closure of Patent Ductus Arteriosus Preterm Thrombocytopenia Tied to Delayed Closure of Patent Ductus Arteriosus
Thrombocytopenia is an independent risk factor for failure of patent ductus arteriosus (PDA) closure and more hemodynamically significant PDA in preterm infants, according to new findings from India.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - September 30, 2016 Category: Radiology Tags: Pediatrics News Source Type: news

Spleen stiffness correlates with cirrhosis complication
The progression of thrombocytopenia, or blood platelet deficiency, in cirrhotic...Read more on AuntMinnie.comRelated Reading: Can elastography help guide breast cancer treatment? Shear-wave elastography can predict esophageal varices Fans of contrast ultrasound celebrate FDA approval Quantitative ultrasound method stages fatty liver Panel says elastography has value for liver fibrosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 2, 2016 Category: Radiology Source Type: news

Rigel's Bleeding Disorder Drug Clears First of Two Key Trials Rigel's Bleeding Disorder Drug Clears First of Two Key Trials
Rigel Pharmaceuticals Inc said its experimental drug to treat chronic immune thrombocytopenia (ITP) met its main goal in the first of two late-stage trials, sending its shares up 12 pct in premarket trade.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 1, 2016 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Genetics Home Reference: immune thrombocytopenia
https://ghr.nlm.nih.gov/condition/immune-thrombocytopenia (Source: NLM General Announcements)
Source: NLM General Announcements - August 30, 2016 Category: Databases & Libraries Source Type: news

Thrombocytopenia (Low Platelet Count)
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 13, 2016 Category: Journals (General) Source Type: news

Utah Resident Becomes First Zika-Related Death In U.S.
By Julie Steenhuysen CHICAGO (Reuters) - The Centers for Disease Control and Prevention has confirmed that a Utah resident’s death last month is the first Zika-related death in the continental United States, the CDC said in an emailed statement. Health officials in the Salt Lake County health department in Utah reported the death on Friday of an elderly resident who had been infected with the Zika virus while traveling to an area with active transmission of the virus. The exact cause of death is not known, the health department said in a press release. The resident had an undisclosed health condition and had tested p...
Source: Healthy Living - The Huffington Post - July 8, 2016 Category: Consumer Health News Source Type: news

Case 2: Neonate with Cholestasis, Thrombocytopenia, and Hypoglycemia
(Source: NeoReviews recent issues)
Source: NeoReviews recent issues - June 30, 2016 Category: Pediatrics Authors: Velazquez, D. M., Ovchinsky, N., Taragin, B., Bruno, C. J. Tags: Pediatric Drug Labeling Update Index of Suspicion in the Nursery Source Type: news

Legal Briefs: In Utero Cerebral Hemorrhage and Alloimmune Thrombocytopenia: Was It Preventable?
(Source: NeoReviews recent issues)
Source: NeoReviews recent issues - June 30, 2016 Category: Pediatrics Authors: Sims, M. E. Tags: Pediatric Drug Labeling Update Index of Suspicion in the Nursery Source Type: news

Cells Detachment
Easy, Gentle and CompleteI often get asked if trypsin is the best reagent to detach primary and stem cells. The problem with a trypsin is that it could lyse a percentage of the cells.We recommend our DetachinTM. It offers the following benefits:Gentle and rapid detachment.Maximum cell viability.Effective on a wide range of cells.No mammalian or bacterial byproducts.Stable at 4°C for 2 months.No need to wash detached cells.Here's a recent publication referencing the use of Detachin: Yu Hou, Qi Feng, Miao Xu, Guo-sheng Li, Xue-na Liu, Zi Sheng, Hai Zhou, Ji Ma, Yu Wei,1 Yuan-xin Sun,Ying-yi Yu, Ji-hua Qiu, Lin-lin S...
Source: Neuromics - June 28, 2016 Category: Neuroscience Tags: Astrocyte-Glial-Neuron Co-cultures Cell based assays Detachin Neurons stem cell based assays Source Type: news

Thrombocytopenia After Reversal of Anticoagulation for SurgeryThrombocytopenia After Reversal of Anticoagulation for Surgery
What was the cause of the sudden development of severe thrombocytopenia in this patient post-surgical blood transfusions? Laboratory Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 20, 2016 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

Inherited thrombocytopenia type is a risk factor for hematologic cancers
Copenhagen – Investigators in Italy have found that a recently identified form of inherited thrombocytopenia related to mutations in the gene ETV6 (ETV6-RT) appears to be largely asymptomatic, but... (Source: Pediatric News)
Source: Pediatric News - June 11, 2016 Category: Journals (General) Source Type: news

Inherited thrombocytopenia type is a risk factor for hematologic cancers
Copenhagen – Investigators in Italy have found that a recently identified form of inherited thrombocytopenia related to mutations in the gene ETV6 (ETV6-RT) appears to be largely asymptomatic, but... (Source: Family Practice News)
Source: Family Practice News - June 11, 2016 Category: Primary Care Source Type: news

CDC Reports First U.S. Zika Death In Puerto Rico
Puerto Rico has 683 confirmed cases of the Zika virus, including 65 pregnant women with symptoms of the virus and one death, U.S. health officials said on Friday. Officials who have been tracking cases of the mosquito-borne illness since December, say five patients with suspected cases of the paralyzing nerve disorder Guillain-Barre syndrome have tested positive for the Zika virus, according to a report published by the U.S. Centers for Disease Control and Prevention. The CDC also reported that one patient with a confirmed Zika infection died from severe thrombocytopenia, a disorder marked by abnormally low blood platelets...
Source: Healthy Living - The Huffington Post - April 29, 2016 Category: Consumer Health News Source Type: news

Make the Diagnosis: Smear Savvy
(MedPage Today) -- Case Findings: A 45-year old male patient with no significant past medical history presents with recurrent fevers, fatigue, arthralgias, and general malaise that have persisted for the past two months. He denies any weight loss, nausea, vomiting, abdominal pain, or headaches. He is a Boy Scout leader who spent the summer chaperoning at a Boy Scout camp. A physical examination shows fever, scleral icterus, and mild hepatosplenomegaly. Laboratory studies reveal anemia, elevated lactate dehydrogenase, thrombocytopenia, elevated total bilirubin, low haptoglobin, reticulocytosis, elevated liver enzymes, a...
Source: MedPage Today Public Health - April 21, 2016 Category: American Health Source Type: news

Nplate® (Romiplostim) Study In The Lancet Shows Significant Increase In Durable Platelet Response Among Children With Immune Thrombocytopenia
Nplate Reduced Rates of Bleeding by More Than 30 Percent in Children Affected by Blood Disorder THOUSAND OAKS, Calif., April 19, 2016 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that The Lancet published results from a Phase 3 randomized, double-blind, placebo-controlled study of Nplate® (romiplostim) in children with symptomatic immune thrombocytopenia (ITP). The study showed that 52 percent of Nplate patients achieved a durable platelet response, compared with 10 percent of placebo-treated patients (p=0.002, odds ratio 9.1, 95 percent CI: 1.9, 43.2). "Children with ITP are at risk for seriou...
Source: Amgen News Release - April 19, 2016 Category: Pharmaceuticals Tags: Uncategorized Source Type: news